Boehringer Ingelheim Animal Health USA Inc. will create 225 jobs and invest more than $120 million in Georgia’s Gwinnett, Clarke, and Hall counties. The animal health company has located its North American headquarters in Duluth, creating 75 new jobs; is adding more than 100 new jobs at its manufacturing and R&D facility in Athens; and is creating more than 50 jobs at the company’s Gainesville manufacturing facility.
“For nearly 40 years, the company and its predecessors have helped make the state of Georgia a key player in animal health — from its beginning producing rabies vaccines in Athens, to multiple facilities today, that are playing an instrumental role in advancing animal health and well-being,” said Everett Hoekstra, president of Boehringer Ingelheim Animal Health USA Inc. “Our investments will expand our capabilities and presence in Georgia, and drive future growth and innovation to help prevent disease in livestock and pets.”
Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing, and marketing new medications of high therapeutic value for human and veterinary medicine.
“We’re excited to welcome Boehringer Ingelheim Animal Health USA Inc. to the Peach State,” said Governor Brian P. Kemp. “As a family-owned business, they will join a first-class corporate family here in Georgia. I look forward to working with them to strengthen our university system and existing industries in agribusiness, health technology, and science.”
“Boehringer Ingelheim is a global leader that prides itself on improving the lives of both humans and animals, and we are proud to have the Animal Health USA headquarters in Gwinnett County,” said Gwinnett County Commission Chair Charlotte Nash. “Boehringer Ingelheim recognizes that Gwinnett is a robust technology and life science hub, and that we can provide the talented workforce and vibrant connectivity they need to thrive. We look forward to their continued success in our community.”
“Boehringer Ingelheim is an innovative leader in the global bioscience community, with strong roots in Athens-Clarke County,” said Mayor Kelly Girtz, IDA. “This important expansion is a product of the company’s commitment to our community and the talent in Athens dating back to 1989. We look forward to an existing industry continuing to contribute to the unique vitality of Athens-Clarke County.”
“Boehringer Ingelheim has demonstrated a commitment to reinvest in the people, research, and technology that make their business a leader in life sciences and animal health,” said Mayor Danny Dunagan, City of Gainesville. “Boehringer Ingelheim’s Gainesville-Hall County location plays a key role in poultry vaccine production that is so important to animal health and prevention. This community takes great pride in being a partner with Boehringer Ingelheim and their Georgia team.”
Georgia Department of Economic Development (GDEcD) Special Projects Director E. Jane Caraway represented the Global Commerce Division in partnership with Partnership Gwinnett, Greater Hall of Chamber of Commerce, Athens-Clarke County Economic Development, Georgia Power, University of Georgia, and the Metro Atlanta Chamber.
“It’s a great day in Georgia when we can announce that a project will spur job creation in three counties,” said GDEcD Commissioner Pat Wilson. “Boehringer Ingelheim’s new US animal health headquarters and dual expansions are a testament to our colleges and universities as well the resources surrounding agribusiness and veterinary sciences in Georgia.”
Relocating or Expanding Your Business In Georgia
Considering Georgia for your company’s relocation or expansion project? Check out Business Facilities’ Georgia Incentives and Workforce Development Guide for a comprehensive list of financial aid, loans, grants, abatements, workforce development, exemptions, funds and capital investment opportunities.
